Dental caries vaccines: Prospects and concerns

Critical Reviews in Oral Biology and Medicine

Volumn 13, Issue 4, 2002, Pages 335-349

  Smith, D J ^a  

^a FORSYTH INSTITUTE   (United States)

Author keywords

Antigen I II; Glucan binding protein; Glucosyltransferase; Mutans streptococci; Secretory IgA

Indexed keywords

ADHESIN; ADJUVANT; BINDING PROTEIN; BRD 509; CHIMERIC PROTEIN; CHOLERA TOXIN; DINITROPHENYL BOVINE SERUM ALBUMIN; GLUCAN BINDING PROTEIN A; GLUCAN BINDING PROTEIN B; GLUCAN BINDING PROTEIN C; GLUCOSYLTRANSFERASE; HYBRID PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A2; INTERLEUKIN 5; INTERLEUKIN 6; LIPOSOME; LYSOPHOSPHATIDYLCHOLINE; MICROSPHERE; OLIGODEOXYNUCLEOTIDE; OMZ 175; POLYGLACTIN; SUBUNIT VACCINE; SURFACE PROTEIN ANTIGEN A; SYNTHETIC PEPTIDE; TETANUS TOXOID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINE; VACCINE PACA;

ACTIVE IMMUNIZATION; BACTERIAL COLONIZATION; DENTAL CARIES; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; HOST RESISTANCE; HUMAN; IMMUNOGENICITY; MICROCAPSULE; MUCOSAL IMMUNITY; NONHUMAN; ONTOGENY; PASSIVE IMMUNIZATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STREPTOCOCCUS;

EID: 0036928730     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/154411130201300404     Document Type: Review

References (155)

1. Abo H, Masumura T, Kodama T, Ohta H, Fukui K, Kato K, et al. (1991). Peptide sequences for sucrose splitting and glucan binding within Streptococcus sobrinus glucosyltransferase (water-insoluble glucan synthetase). J Bacteriol 173:989-996.
2. Avery OT, Goebel WF (1929). Chemo-immunological studies on conjugated carbohydrate-proteins. II. Immunological specificity of synthetic sugar-proteins. J Exp Med 50:521-533.
3. Banas JA, Russell RR, Ferretti JJ (1990). Sequence analysis of the gene for the glucan-binding protein of Streptococcus mutans Ingbritt. Infect Immun 58:667-673.
4. Berkowitz RJ, Jones P (1985). Mouth-to-mouth transmission of the bacterium Streptococcus mutans between mother and child. Arch Oral Biol 30:377-379.
5. Boyaka PN, Wright PF, Marinaro M, Kiyono H, Johnson JE, Gonzales RA, et al. (2000). Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils. Am J Pathol 157:2023-2035.
6. Brandtzaeg P (1996). The B-cell development in tonsillar lymphoid follicles. Acta Otolaryngol 523(Suppl 6):55-59.
7. Brandtzaeg P, Haneberg B (1997). Role of nasal-associated lymphoid tissue in the human mucosal immune system. Mucosal Immunol Update 5:4-8.
8. Caufield PW, Walker TM (1989). Genetic diversity within Streptococcus mutans evident from chromosomal DNA restriction fragment polymorphisms. J Clin Microbiol 27:274-278.
9. Caufield PW, Cutter GR, Dasanayake AP (1993). Initial acquisition of mutans streptococci by infants: Evidence for a discrete window of infectivity. J Dent Res 72:37-45.
10. Challacombe SJ, Rahman D, Jeffery H, Davis SS, O'Hagan DT (1992). Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology 76:164-168.
11. Chia JS, Lin RH, Lin SW, Chen JY, Yang CS (1993). Inhibition of glucosyltransferase activities of Streptococcus mutans by a monoclonal antibody to a subsequence peptide. Infect Immun 61:4689-4695.
12. Chia JS, Lin SW, Yang CS, Chen JY (1997). Antigenicity of a synthetic peptide from glucosyltransferases of Streptococcus mutans in humans. Infect Immun 65:1126-1130.
13. Childers NK, Denys FR, McGee NF, Michalek SM (1990). Ultrastructural study of liposome uptake by M cells of rat Peyer's patch: An oral vaccine system for delivery of purified antigen. Reg Immunol 3:8-16.
14. Childers NK, Michalek SM, Pritchard DG, McGhee JR (1990-1991). Mucosal and systemic responses to an oral liposome-Streptococcus mutans carbohydrate vaccine in humans. Reg Immunol 3:289-296.
15. Childers NK, Zhang SS, Michalek SM (1994). Oral immunization of humans with dehydrated liposomes containing Streptococcus mutans glucosyltransferase induces salivary immunoglobulin A2 antibody responses. Oral Microbiol Immunol 9:146-153.
16. Childers NK, Zhang SS, Harokopakis E, Harmon CC, Michalek SM (1996). Properties of practical oral liposome - Streptococcus mutans glucosyltransferase vaccines for effective induction of caries protection. Oral Microbiol Immunol 11:172-180.
17. Childers NK, Tong G, Michalek SM (1997). Nasal immunization of humans with dehydrated liposomes containing Streptococcus mutans antigen. Oral Microbiol Immunol 12:329-335.
18. Childers NK, Tong G, Mitchell S, Kirk K, Russell MW, Michalek SM (1999). A controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responses. Infect Immun 67:618-623.
19. Childers NK, Miller KL, Tong G, Llarena JC, Greenway T, Ulrich JT, et al. (2000). Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen. Infect Immun 68:5509-5516.
20. Crawford JM, Taubman MA, Smith DJ (1975). Minor salivary glands as a major source of secretory immunoglobulin A in the human oral cavity. Science 190:1206-1209.
21. Crowley PJ, Brady LJ, Piacentini DA, Bleiweis AS (1993). Identification of a salivary agglutinin-binding domain within cell surface adhesin P1 of Streptococcus mutans. Infect Immun 61:1547-1552.
22. Czerkinsky C, Russell MW, Lycke N, Lindblad M, Holmgren J (1989). Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect Immun 57:1072-1077.
23. Demuth DR, Lammey MS, Huck M, Lally ET, Malamud D (1990). Comparison of Streptococcus mutans and Streptococcus sanguis receptors for human salivary agglutinin. Microbiol Pathogen 9:199-211.
24. Dertzbaugh MT, Macrina FL (1990). Inhibition of Streptococcus mutans glucosyltransferase activity by antiserum to a subsequence peptide. Infect Immun 58:1509-1513.
25. Dertzbaugh MT, Peterson DL, Macrina FL (1990). Cholera toxin B-subunit gene fusion: Structural and functional analysis of the chimeric protein. Infect Immun 58:70-79.
26. Devulapalle KS, Goodman SD, Gao Q, Hemsley A, Mooser G (1997). Knowledge-based model of a glucosyltransferase from the oral bacterial group of mutans streptococci. Protein Sci 6:2489-2493.
27. Dickinson BL, Clements JD (1995). Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun 63:1617-1623.
28. Dougan G, Hormaeche CE, Maskell DJ (1987). Live oral Salmonella vaccines: Potential use of attenuated strains as carriers of heterologous antigens to the immune system. Parasite Immunol 9:151-160.
29. Eastcott JW, Holmberg CJ, Dewhirst FE, Esch TR, Smith DJ, Taubman MA (2001). Oligonucleotide CpG motifs enhance immune response to mucosally or systemically administered tetanus toxoid. Vaccine 19:1636-1642.
30. Eldridge JH, Hammond CJ, Meulbroek JA, Staas JK, Gilley RM, Tice TR (1990). Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J Controlled Release 11:205-214.
31. Ermak TH, Dougherty EP, Bhagat HR, Kabok Z, Pappo J (1995). Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer's patch M cells. Cell Tissue Res 279:433-436.
32. Filler SJ, Gregory RL, Michalek SM, Katz J, McGhee JT (1991). Effect of immune bovine milk on Streptococcus mutans in human dental plaque. Arch Oral Biol 36:41-47.
33. Fontana M, Dunipace AJ, Stookey GK, Gregory RL (1999). Intranasal immunization against dental caries with a Streptococcus mutans enriched fimbrial preparation. Clin Diagn Lab Immunol 6:405-409.
34. Freytag LC, Clements JD (1999). Bacterial toxins as mucosal adjuvants. Curr Top Microbiol Immunol 236:215-236.
35. Fukuizumi T, Inoue H, Tsujisawa T, Uchiyama C (1999). Tonsillar application of formalin-killed cells of Streptococcus sobrinus reduces experimental dental caries in rabbits. Infect Immun 67:426-428.
36. Funane K, Shiraiwa M, Hashimoto K, Ichishima E, Kobayashi M (1993). An active-site peptide containing the second essential carboxyl group of dextran sucrose from Leuconostoc mesenteroides by chemical modifications. Biochem 32:13696-13702.
37. Gangloff S, M'Zoughi R, Lett E, Scholler M, Baer J, Pini A, et al. (1992). Epitope mapping of Streptococcus mutans SR protein and human IgG cross-reactive determinants, by using recombinant proteins and synthetic peptides. J Immunol 148:3249-3255.
38. Gibbons RJ, van Houte J (1975). Dental caries. Ann Rev Med 26:121-136.
39. Gibbons RJ, Cohen L, Hay DI (1986). Strains of Streptococcus mutans and Streptococcus sobrinus attach to different pellicle receptors. Infect Immun 52:555-561.
40. Gilmore KS, Russell RRB, Ferretti JJ (1990). Analysis of the Streptococcus downei gtfS gene, which specifies a glucosyltransferase that synthesizes soluble glucans. Infect Immun 58:2452-2458.
41. Haas W, Banas JA (2000). Ligand-binding properties of the carboxyl-terminal repeat domain of Streptococcus mutans glucan-binding protein A. J Bacteriol 182:728-733.
42. Hajishengallis G, Michalek SM (1999). Current status of a mucosal vaccine against dental caries. Oral Microbiol Immunol 14:1-20.
43. Hajishengallis G, Nikolova E, Russell MW (1992). Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A (S-IgA) antibodies to cell surface protein antigen I/II: Reversal by IgA1 protease cleavage. Infect Immun 60:5057-5064.
44. Hajishengallis G, Hollingshead SK, Koga T, Russell MW (1995). Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol 154:4322-4332.
45. Hajishengallis G, Harokopakis E, Hollingshead SK, Russell MW, Michalek SM (1996a). Construction and oral immunogenicity of a Salmonella typhimurium strain expressing a streptococcal adhesin linked to the A2/B subunits of cholera toxin. Vaccine 14:1545-1548.
46. Hajishengallis G, Michalek SM, Russell MW (1996b). Persistence of serum and salivary antibody responses after oral immunization with a bacterial protein antigen genetically linked to the A2/B subunits of cholera toxin. Infect Immun 64:665-667.
47. Hajishengallis G, Russell MW, Michalek SM (1998). Comparison of an adherence domain and a structural region of Streptococcus mutans antigen I/II in protective immunity against dental caries in rats after intranasal immunization. Infect Immun 66:1740-1743.
48. Hamada S, Horikoshi T, Minami T, Kawabata S, Hiraoka J, Fujiwara T, et al. (1991). Oral passive immunization against dental caries in rats by use of hen egg yolk antibodies specific for cell-associated glucosyltransferase of Streptococcus mutans. Infect Immun 59:4161-4167.
49. Harrod T, Martin M, Russell MW (2001). Long-term persistence and recall of immune responses in aged mice after mucosal immunization. Oral Microbiol Immunol 16:170-177.
50. Hatta H, Tsuda K, Ozeki M, Kim M, Yamamoto T, Otake S, et al. (1997). Passive immunization against dental plaque formation in humans: Effect of a mouth rinse containing egg yolk antibodies (IgY) specific to Streptococcus mutans. Caries Res 31:268-274.
51. Honda O, Karo C, Kuramitsu HK (1990). Nucleotide sequence of the Streptococcus mutans gtfD gene encoding the glucosyltransferase-S enzyme. J Gen Microbiol 136:2099-2105.
52. Hsu YY, Gresser JD, Stewart RR, Trantolo DJ, Lyons CM, Simons GA, et al. (1996). Mechanisms of isoniazid release from poly(d,f lactide-co-glycolide) matrices prepared by dry-mixing and low density polymeric foam methods. J Pharm Sci 86:706-713.
53. Huang Y, Hajishengallis G, Michalek SM (2000). Construction and characterization of a Salmonella enterica serovar typhimurium clone expressing a salivary adhesin of Streptococcus mutans under control of the anaerobically inducible nirB promoter. Infect Immun 68:1549-1556.
54. Huang Y, Hajishengallis G, Michalek SM (2001). Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter. Infect Immun 69:2154-2161.
55. Hvalbye BK, Aaberge IS, Lovik M, Haneberg B (1999). Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection. Infect Immun 67:4320-4325.
56. Inoue H, Fukuizumi T, Tsujisawa T, Uchiyama C (1999). Simultaneous induction of specific immunoglobulin A-producing cells in major and minor salivary glands after tonsillar application of antigen in rabbits. Oral Microbiol Immunol 14:21-26.
57. Jespersgaard C, Hajishengallis G, Huang Y, Russell MW, Smith DJ, Michalek SM (1999). Protective immunity against Streptococcus mutans infection in mice after intranasal immunization with the glucan-binding region of S. mutans glucosyltransferase. Infect Immun 67:6543-6549.
58. Kaseda K, Yokota H, Ishii Y, Yanagida T, Inoue T, Fukui K, et al. (2000). Single-molecule imaging of interaction between dextran and glucosyltransferase from Streptococcus sobrinus. J Bacteriol 182:1162-1166.
59. Katz J, Harmon CC, Buckner GP, Richardson GJ, Russell MW, Michalek SM (1993). Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin. Infect Immun 61:1964-1971.
60. Kelly CG, Todryk S, Kendal HL, Munro GH, Lehner T (1995). T-cell, adhesion, and B-cell epitopes of the cell surfaces Streptococcus mutans protein antigen I/II. Infect Immun 63:3649-3658.
61. Kleanthous H, Myers GA, Georgakopoulos KM, Tibbitts TJ, Ingrassia JW, Gray HL, et al. (1998). Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun 66:2879-2886.
62. Kohler B, Andreen I, Jonsson B (1984). The effect of caries-preventive measures in mothers on dental caries and the oral presence of the bacteria Streptococcus mutans and lactobacilli in their children. Arch Oral Biol 29:879-883.
63. Konishi N, Torii Y, Yamamoto T, Miyagi A, Ohta H, Fukui K, et al. (1999). Structure and enzymatic properties of genetically truncated forms of the water-insoluble glucan-synthesizing glucosyltransferase from Streptococcus sobrinus. J Biochem (Tokyo) 126:287-295.
64. Laloi P, Munro CL, Jones KR, Macrina FL (1996). Immunologic characteristics of a Streptococcus mutans glucosyltransferase B sucrose-binding site peptide-cholera toxin B-subunit chimeric protein. Infect Immun 64:28-36.
65. Lam A, Smith D, Barnes L, Clements JD, Wise D, Taubman MA (2001). Alternate routes for dental caries vaccine delivery. J Dent Res 80:124.
66. Lamont RJ, Demuth DR, Davis CA, Malamud D, Rosan B (1991). Salivary-agglutinin-mediated adherence of Streptococcus mutans to early plaque bacteria. Infect Immun 59:3446-3450.
67. Landsteiner K (1936). The Specificity of Serological Reactions. Cambridge, MA: Harvard University Press.
68. LaPolla RJ, Haron JA, Kelly CG, Taylor WR, Bohart C, Hendricks M, et al. (1991). Sequence and structural analysis of surface protein antigen I/II(SpaA) of Streptococcus sobrinus. Infect Immun 59:2677-2685.
69. Lee SF, Progulske-Fox A, Bleiweis AS (1988). Molecular cloning and expression of a Streptococcus mutans major surface protein antigen P1 (I/II) in Escherichia coli. Infect Immun 56:2114-2119.
70. Lehner T, Russell MW, Caldwell J, Smith R (1981). Immunization with purified protein antigen from Streptococcus mutans against dental caries in rhesus monkeys. Infect Immun 34:407-415.
71. Lehner T, Haron J, Bergmeier LA, Mehlert A, Beard R, Dodd M, et al. (1989a). Local oral immunization with synthetic peptides induces a dual mucosal IgG and salivary IgA antibody responses and prevents colonization of S. mutans. Immunol 67:419-424.
72. Lehner T, Walker P, Bergmeier LA, Haron JA (1989b). Immunogenicity of synthetic peptides derived from the sequences of a Streptococcus mutans cell surface antigen in nonhuman primates. J Immunol 143:2699-2705.
73. Lehner T, Ma JK, Kelly CG (1992). A mechanism of passive immunization with monoclonal antibodies to a 185,000 M(r) streptococcal antigen. Adv Exp Med Biol 327:151-163.
74. Lehner T, Ma JK, Munro G, Walker P, Childerstone A, Todryk S, et al. (1994). T-cell and B-cell epitope mapping and construction of peptide vaccines. In: Molecular Pathogenesis of Periodontal Disease. Genco RJ, Hamada S, Lehner T, McGhee JR, Mergenhagen S, editors. Washington, DC: ASM Press, pp. 279-292.
75. Lett E, Gangloff M, Zimmermann D, Wachsmann D, Klein JP (1994). Immunogenicity of polysaccharides conjugated to peptides containing T and B-cell epitopes. Infect Immun 62:785-792.
76. Lett E, Klopfenstein C, Klein JP, Scholler M, Wachsmann D (1995). Mucosal immunogenicity of polysaccharides conjugated to a peptide or multiple-antigen peptide containing T- and B-cell epitopes. Infect Immun 63:2645-2651.
77. Li Y, Caufield PW (1995). The fidelity of initial acquisition of mutans streptococci by infants from their mothers. J Dent Res 74:681-685.
78. Lis M, Shiroza T, Kuramitsu HK (1995). Role of C-terminal direct repeating units of the Streptococcus sobrinus glucosyltransferase-S in glucan binding. Appl Environ Microbiol 61:2040-2042.
79. Loesche WJ (1986). Role of Streptococcus mutans in human dental decay. Microbiol Rev 50:353-380.
80. Ma JK, Hunjan M, Smith R, Kelly C, Lehner T (1990). An investigation into the mechanism of protection by local passive immunization with monoclonal antibodies against Streptococcus mutans. Infect Immun 58:3407-3414.
81. Ma JK, Kelly CG, Munro G, Whiley RA, Lehner T (1991). Conservation of the gene encoding streptococcal antigen I/II in oral streptococci. Infect Immun 59:2686-2694.
82. Ma JK, Hikmat BY, Wycoff K, Vine ND, Chargelegue D, Yu L, et al. (1998). Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nature Med 4:601-606.
83. MacGregor E, Jespersen HM, Svensson B (1996). A circularly permuted alpha amylase-type alpha/beta barrel structure in glucan-synthesizing glucosyltransferases. FEBS Lett 378:263-266.
84. Martin M, Metzger DJ, Michalek SM, Connell TD, Russell MW (2000). Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb. Infect Immun 68:281-287.
85. Martin M, Hajishengallis G, Metzger DJ, Michalek SM, Connell TD, Russell MW (2001). Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells. Infect Immun 69:252-261.
86. Mattos-Graner RO, Rontani RM, Gaviao MB, Bocatto HA (1996). Caries prevalence in 6-36-month-old Brazilian children. Community Dent Health 13:96-98.
87. Mattos-Graner RO, Smith DJ, King WF, Mayer MPA (2000). Water-insoluble glucan synthesis by mutans streptococcal strains correlates with caries incidence in 12- to 30-month-old children. J Dent Res 79:1371-1377.
88. Mattos-Graner RO, Li Y, Caufield PW, Duncan M, Smith DJ (2001). Genotypic diversity of mutans streptococci in Brazilian nursery children suggests horizontal transmission. J Clin Microbiol 39:2313-2316.
89. McCluskie MJ, Davis HL (2000). Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants. Vaccine 19:413-422.
90. Mestecky J (1993). Saliva as a manifestation of the common mucosal immune system. Ann NY Acad Sci 694:184-194.
91. Michalek SM, McGhee JR, Mestecky J, Arnold RR, Bozzo L (1976). Ingestion of Streptococcus mutans induces secretory IgA and caries immunity. Science 192:1238-1240.
92. Milgrom P, Riedy CA, Weinstein P, Tanner AC, Manibusan L, Bruss J (2000). Dental caries and its relationship to bacterial infection, hypoplasia, diet, and oral hygiene in 6- to 36-month-old children. Community Dent Oral Epidemiol 28:295-306.
93. Monchois V, Vignon M, Escalier PC, Svensson B, Russell RR (2000). Involvement of Gln937 of Streptococcus downei GTF-I glucansucrase in transition-state stabilization. Eur J Biochem 267:4127-4136.
94. Montgomery PC, Rafferty DE (1998). Induction of secretory and serum antibody responses following oral administration of antigen with bioadhesive degradable starch microparticles. Oral Microbiol Immunol 13:139-149.
95. Mooser G, Wong C (1988). Isolation of a glucan-binding domain of glucosyltransferase (1,6-alpha-glucan synthase) from Streptococcus sobrinus. Infect Immun 56:880-884.
96. Mooser G, Hefta SA, Paxton RJ, Shively JE, Lee T (1991). Isolation and sequence of an active-site peptide containing a catalytic aspartic acid from two Streptococcus sobrinus glucosyltransferases. J Biol Chem 266:8916-8922.
97. Nair PN, Schroeder HE (1983). Retrograde access of antigens to the minor salivary glands in the monkey Macaca fascicularis. Arch Oral Biol 28:145-152.
98. Nakai M, Okahashi N, Ohta H, Koga T (1993). Saliva-binding region of Streptococcus mutans surface protein antigen. Infect Immun 61:433-4349.
99. Neutra MR, Kraehenbuhl JP (1992). Transepithelial transport and mucosal defense. I. The role of M cells. Trends Cell Biol 2:134-138.
100. Oho T, Shimazaki Y, Mitoma M, Yoshimura M, Yamashita Y, Okano K, et al. (1999). Bovine milk antibodies against cell surface protein antigen PAc-glucosyltransferase fusion protein suppress cell adhesion and alter glucan synthesis of Streptococcus mutans. J Nutr 129:1836-1841.
101. Porgador A, Staats HF, Faiola B, Gilboa E, Palker TJ (1997). Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo. J Immunol 158:834-841.
102. Pucci MJ, Jones KR, Kuramitsu HK, Macrina FL (1987). Molecular cloning and characterization of the glucosyltransferase C gene (gtfC) from Streptococcus mutans LM7. Infect Immun 55:2176-2182.
103. Rafferty DE, Elfaki MG, Montgomery PC (1996). Preparation and characterization of a biodegradable microparticle antigen/cytokine delivery system. Vaccine 14:532-538.
104. Redman TK, Harmon CC, Michalek SM (1994). Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: Persistence and induction of humoral responses in rats. Infect Immun 62:3162-3171.
105. Redman TK, Harmon CC, Lallone RL, Michalek SM (1995). Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: Dose response and induction of protective humoral responses in rats. Infect Immun 63:2004-2011.
106. Russell MW, Lehner T (1978). Characterization of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c. Arch Oral Biol 23:7-15.
107. Russell MW, Wu HY (1991). Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit. Infect Immun 59:4061-4070.
108. Russell RRB (1979). Glucan-binding proteins of Streptococcus mutans serotype c. J Gen Microbiol 112:197-201.
109. Russell RRB, Gilpin ML, Mukasa H, Dougan G (1987). Characterization of glucosyltransferase expressed from a Streptococcus sobrinus gene cloned in Escherichia coli. J Gen Microbiol 133:935-944.
110. Sato Y, Yamamoto Y, Harutoshi K (1997). Cloning and sequence analysis of the GbpC gene encoding a novel glucan-binding protein of Streptococcus mutans. Infect Immun 65:668-675.
111. Schroeder HE, Moreillon MC, Nair PN (1983). Architecture of minor salivary gland duct/lymphoid follicle associations and possible antigen-recognition sites in the monkey Macacafascicularis. Arch Oral Biol 28:133-143.
112. Shiroza T, Ueda S, Kuramitsu HK (1987). Sequence analysis of the gtfB gene from Streptococcus mutans. J Bacteriol 169:4263-4270.
113. Smith DJ, Taubman MA (1987). Oral immunization of humans with Streptococcus sobrinus glucosyltransferase. Infect Immun 55:2562-2569.
114. Smith DJ, Taubman MA (1990). Effect of local deposition of antigen on salivary immune responses and reaccumulation of mutans streptococci. J Clin Immunol 10:273-281.
115. Smith DJ, Taubman MA (1992). Ontogeny of immunity to oral microbiota. Crit Rev Oral Biol Med 3:109-133.
116. Smith DJ, Taubman MA (1993). Emergence of immune mechanisms in saliva. Crit Rev Oral Biol Med 4:335-341.
117. Smith DJ, Taubman MA (1996). Experimental immunization of rats with a Streptococcus mutans 59 kDa glucan binding protein protects against dental caries. Infect Immun 64:3069-3073.
118. Smith DJ, Taubman MA (1997). Vaccines for dental caries. In: New Generation Vaccines. Levine MM, Woodrow GC, Kaper JB, Cobon GS, editors. New York: Marcel Dekker Inc., pp. 913-930.
119. Smith DJ, Taubman MA, Ebersole JL (1978). Effects of local immunization with glucosyltransferase fractions from Streptococcus mutans on dental caries in hamsters caused by homologous and heterologous serotypes of Streptococcus mutans. Infect Immun 21:843-851.
120. Smith DJ, Taubman MA, Ebersole JL (1979). Effect of oral administration of glucosyltransferase antigens on experimental dental caries. Infect Immun 26:81-89.
121. Smith DJ, Taubman MA, Ebersole JL (1981). Effects of local immunization with glucosyltransferase antigens from Strep. sanguis on dental caries caused by Strep. mutans. Arch Oral Biol 26:871-878.
122. Smith DJ, Taubman MA, Ebersole JL (1983). Effects of local immunization of hamsters with glucosyltransferase antigens on infection with Streptococcus sanguis. Infect Immun 42:156-162.
123. Smith DJ, Taubman MA, Holmberg CJ, Eastcott J, King WF, Ali-Salaam P (1993a). Antigenicity and immunogenicity of a synthetic peptide derived from a glucan-binding domain of mutans streptococcal glucosyltransferase. Infect Immun 61:2899-2905.
124. Smith DJ, Anderson JM, King WF, van Houte J, Taubman MA (1993b). Oral streptococcal colonization of infants. Oral Microbiol Immunol 8:1-4.
125. Smith DJ, Akita H, King WF, Taubman MA (1994a). Purification and antigenicity of a novel glucan binding protein of Streptococcus mutans. Infect Immun 62:2545-2552.
126. Smith DJ, Taubman MA, King WF, Eida S, Powell JR, Eastcott JW (1994b). Immunological characteristics of a synthetic peptide associated with a catalytic domain of mutans streptococcal glucosyltransferase. Infect Immun 62:5470-5476.
127. Smith DJ, Heschel RL, Melvin J, King WF, Pereira MBB, Taubman MA (1997a). Streptococcus mutans glucan binding proteins as dental caries vaccines. In: Mucosal Solutions. Advances in Mucosal Immunology. Vol. 2. Husband AJ, Beagley KW, Clancy RL, Collins AM, Cripps AW, Emery DL, editors. Sydney, Australia: University of Sydney Press, pp. 367-377.
128. Smith DJ, Shoushtari B, Heschel RL, King WF, Taubman MA (1997b). Immunogenicity and protective potential of peptides derived from a hypothetical second GTF catalytic domain. Infect Immun 65:4424-4430.
129. Smith DJ, King WF, Akita H, Taubman MA (1998a). Association of salivary IgA antibody and initial mutans streptococcal infection. Oral Microbiol Immunol 13:278-285.
130. Smith DJ, King WF, Wu CD, Shen BI, Taubman MA (1998b). Structural and antigenic characteristics of Streptococcus sobrinus glucan binding proteins. Infect Immun 66:5565-5569.
131. Smith DJ, Heschel R, King WF, Taubman MA (1999). Antibody to glucosyltransferase induced by synthetic peptides associated with catalytic regions of alpha-amylases. Infect Immun 67:2638-2642.
132. Smith DJ, Trantolo DJ, King WF, Gusek EJ, Fackler PH, Gresser JD, et al. (2000). Induction of secretory immunity with bioadhesive poly(d,l-lactide-co-glycolide) microparticles containing Streptococcus sobrinus glucosyltransferase. Oral Microbiol Immunol 15:124-130.
133. Smith DJ, King WF, Godiska R (2001a). Passive transfer of IgY antibody to Streptococcus mutans glucan binding protein-B can be protective for experimental dental caries. Infect Immun 69:3135-3142.
134. Smith DJ, King WF, Barnes LA, Trantolo D, Wise DL, Taubman MA (2001b). Facilitated intranasal induction of mucosal and systemic immunity to mutans streptococcal glucosyltransferase peptide vaccines. Infect Immun 69:4767-4773.
135. Staat RH, Langley SD, Doyle RJ (1980). Streptococcus mutans adherence: Presumptive evidence for protein-mediated attachment followed by glucan-dependent cellular accumulation. Infect Immun 27:675-681.
136. Takahashi I, Okahashi N, Matsushita K, Tokuda M, Kanamoto T, Munekata E, et al. (1991). Immunogenicity and protective effect against oral colonization by Streptococcus mutans of synthetic peptides of a streptococcal surface protein antigen. J Immunol 146:332-336.
137. Takahashi I, Marinaro M, Kiyono H, Jackson RJ, Nakagawa I, Fujihashi K, et al. (1996). Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J Infect Dis 173:627-635.
138. Taubman MA, Smith DJ (1977). Effects of local immunization with glucosyltransferase on experimental dental caries in rats and hamsters. J Immunol 118:710-720.
139. Taubman MA, Holmberg CJ, Smith DJ (1995). Immunization of rats with synthetic peptide constructs from the glucan binding or catalytic regions of mutans streptococcal glucosyltransferase protects against dental caries. Infect Immun 63:3088-3093.
140. Taubman MA, Smith DJ, Holmberg CJ, Ma B-Y, Shafer D, Lees A (1998). Protein-polysaccharide conjugates as potential caries vaccines (abstract). J Dent Res 77:792.
141. Taubman MA, Smith DJ, Holmberg CJ, Lees A (1999). GTF-S. sobrinus polysaccharide conjugates as potential caries vaccines (abstract). J Dent Res 78:453.
142. Taubman MA, Smith DJ, Holmberg CJ, Eastcott JW (2000). Coimmunization with complementary glucosyltransferase peptides results in enhanced immunogenicity and protection against dental caries. Infect Immun 68:2698-2703.
143. Taubman MA, Holmberg CJ, Smith DJ (2001). Diepitopic construct of functionally relevant complementary peptides enhances immunogenicity, reactivity with glucosyltransferase and protection against dental caries. Infect Immun 69:4210-4216.
144. Tokuda M, Okahashi I, Takahashi M, Nakai S, Nagoika M, Kawagoe M, et al. (1990). Complete nucleotide sequence of the gene for a surface protein antigen of Streptococcus sobrinus. Infect Immun 59:3309-3312.
145. Tsumori H, Minami T, Kuramitsu HK (1997). Identification of essential amino acids in the Streptococcus mutans glucosyltransferases. Infect Immun 179:3391-3396.
146. van Kempen MJ, Rijkers GT, Van Cauwenberge PB (2000). The immune response in adenoids and tonsils. Int Arch Allergy Immunol 122:8-19.
147. van Ruyven FO, Lingstrom P, van Houte J, Kent R (2000). Relationship among mutans streptococci, "low-pH" bacteria, and iodophilic polysaccharide-producing bacteria in dental plaque and early enamel caries in humans. J Dent Res 79:778-784.
148. Wachsmann D, Klein JP, Scholler M, Frank RM (1985). Local and systemic immune response to orally administered liposome-associated soluble Streptococcus mutans cell wall antigens. Immunol 54:189-193.
149. Wachsmann D, Ackersmans F, Vincenzotto C, Scholler M, Bazin H, Ogier J, et al. (1989). Human IgG and Streptococcus mutans SR protein contain crossreactive epitopes. J Immunol 143:4257-4262.
150. Wong C, Hefta SA, Paxton RJ, Shively JE, Mooser G (1990). Size and subdomain architecture of the glucan-binding domain of sucrose: 3-α-D-glucosyltransferase from Streptococcus sobrinus. Infect Immun 58:2165-2170.
151. Wong MC, Lo EC, Schwarz E, Zhang HE (2001). Oral health status and oral health behaviors in Chinese children. J Dent Res 80:1459-1465.
152. Wu HY, Russell MW (1993). Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun 61:314-322.
153. Wu HY, Nguyen HH, Russell MW (1997). Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand J Immunol 46:506-513.
154. Yamashita Y, Bowen WH, Burne RA, Kuramitsu HK (1993). Role of the Streptococcus mutans gtf genes in caries induction in the specific-pathogen free rat model. Infect Immun 61:3811-3817.
155. Yu H, Nakano Y, Yamashita Y, Oho T, Koga T (1997). Effects of antibodies against cell surface protein antigen PAc-glucosyltransferase fusion proteins on glucan synthesis and cell adhesion of Streptococcus mutans. Infect Immun 65:2292-2298.